there's no evidence on how much if any effect it has on the incidence of cardiovascular disease.)
Twenty-three separate meta-analyses were found. Outcomes examined were those of total mortality, cardiovascular mortality and nonfatal cardiovascular disease. As the Table shows, the results of the analyses overwhelmingly supported cholesterol lowering for reduction in nonfatal cardiovascular disease and cardiovascular mortality, but not total mortality. (see original for table)
Garbage in - garbage out?
Of the 23 analyses, eight were not supportive of benefit. Of those eight, three included non-randomised studies, and one didn't state whether it did or not. None of the 15 studies supportive of benefit included non-randomised studies. So here is one lesson learned again: for treatments, including non-randomised studies has to be justified.
The supportive meta-analyses were also generally better designed. Not only did they include only randomised studies, but had more explicit exclusion criteria that allowed a more direct evaluation of the effects of cholesterol lowering without confounding factors. None of the non-supportive meta-analyses included authors with meta-analytic expertise. An interesting post-hoc observation was that only 4 of 10 analyses in British journals were supportive, compared with 11 of 13 in non-British journals
phoenix said:I'm positive lowering of overall BG levels + statins reduced my lipids profile dramatically but how do you separate the 2 ? For me (I think) statins were important to reduce my cholesterol and I did not suffer any obvious ill effect from taking them. However, I have been able to keep them at a fairly low level through diet and reduced BG levels.
results of the analyses overwhelmingly supported cholesterol lowering for reduction in nonfatal cardiovascular disease and cardiovascular mortality, but not total mortality.
Katharine said:The cardiovascular benefits are usually put as relative risk statistics and when numbers needed to treat, side effects and direct costs are considered any benefit to the individual remains very small but possibly statistically relevant to middle aged men who have diabetes or cardiovascular problems.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?